FDA Approved: ENSTILAR — Supplemental Application (LEO Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ENSTILAR (calcipotriol and betamethasone dipropionate) submitted by LEO Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Enstilar (calcipotriene; betamethasone dipropionate)

Snippet

SUPPL AP for ENSTILAR (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)